widespread breast-melanoma knowledgeable leaving Pitt's melanoma Institute - Pittsburgh publish-Gazette

sought after breast-melanoma skilled leaving Pitt's cancer Institute October 10, 2016 11:28 PM

Nancy E. Davidson may be leaving the institution of Pittsburgh's cancer Institute to become govt director of the Fred Hutch/school of Washington cancer Consortium in Seattle.

by means of David Templeton / Pittsburgh submit-Gazette

The director of the college of Pittsburgh cancer Institute is heading to Seattle to turn into the govt director of the Fred Hutch/​college of Washington cancer Consortium.

Or, as she described it, she's exchanging three rivers for Puget Sound.

On Dec. 1, Nancy E. Davidson will count on duties "as a bridge builder across the melanoma treatment, scientific and translational analysis programs" at the Seattle-based cancer middle.

"I have adored Pittsburgh. It's been a very embracing metropolis, and i have cherished the tuition of Pittsburgh and UPMC," she spoke of Monday.

"however I've been serving on the exterior advisory board for Fred Hutch for five years and watching what they're doing and observing their increase. So when i was approached with the chance to be part of the crew and the opportunity to do anything a little bit distinctive — but nevertheless within the melanoma box — I felt I might take what I've discovered in Pittsburgh and practice it to a brand new atmosphere."

Arthur S. Levine, senior vice chancellor for health sciences and the dean of the school of Pittsburgh faculty of medication, mentioned throughout the seven years of Dr. Davidson's management, the Pitt cancer Institute had "improved its deep bench of scientists, added critical new research gives you to continue to be on the cutting edge of cancer analysis, and cemented its standing as the location's best countrywide cancer Institute-particular complete melanoma center."

"we want Nancy well in her new role and appreciate that she is leaving UPCI in such a strong position to lead cancer research well into the longer term," Dr. Levine observed.

A Fred Hutch/​institution of Washington remark described Dr. Davidson as "a good opinion leader in the box of breast cancer biology and remedy" with many published editorials, commentaries and experiences that "supply point of view for key analysis papers as well as essential areas in breast cancer biology and medicine."

Gary Gilliland, president and director of Fred Hutch, mentioned she is an "internationally recognized expert in breast melanoma" with successful leadership at the Pitt cancer Institute, amongst different tremendous positions as a member of the countrywide Academy of medication, past president of the American Society of clinical Oncology and current president of the American association for cancer research.

"She is ideal to additional enrich the already impressive interactions between the Seattle cancer Care Alliance, institution of Washington medicine and Fred Hutch," Dr. Gilliland pointed out. "i am eagerly anticipating working along with her."

Dr. Davidson observed the Pitt cancer Institute is working to take new treatments from analysis "bench to bedside," with clinical trials underway for head and neck melanoma treatments and a colon melanoma vaccine, among others. She talked about she inherited a strong institute when she arrived at Pitt "and that i hope I made it robust adequate" to proceed on its course of development.

Her departure, she said, is bittersweet.

"I'm so grateful for the probability to work in Pittsburgh, and it's been an incredible honor and first-rate pleasure to work with all my colleagues at the tuition of Pittsburgh and UPMC," she pointed out.

Dr. Davidson has a bachelor's diploma from Wellesley faculty and is a 1979 graduate of the Harvard scientific college. She also has held positions at Johns Hopkins school in Baltimore.

David Templeton: dtempleton@post-gazette.com or 412-263-1578.

First published October 10, 2016 5:05 PM

check in for free of charge newsletters and get more of the post-Gazette brought to your inbox Most examine Most Emailed advertisement Most Commented li > a padding:10px 8px; z-index:10; /* Border bottom sits in front of hr for tab effect */ color:#ccc; .most-widget .tw-bs .nav > li > a:focal point outline:none; .most-widget .tw-bs .nav-tabs > li.active > a, .most-widget .tw-bs .nav-tabs > li.active > a:focus, .most-widget .tw-bs .nav-tabs > li.active > a:lively, .most-widget .tw-bs .nav-tabs > li.active > a:hover, .most-widget .tw-bs .nav-tabs > li.lively > a:link, .most-widget .tw-bs .nav-tabs > li.lively > a:visited color:#666; border:1px strong #cecece; border-bottom-colour:#fff; define:none; .most-widget .tw-bs .nav-tabs > li > a > i font-measurement:1.8em; .most-widget .tw-bs ol margin-right:10px; .most-widget .tw-bs ol li margin: 6px 0; .most-widget .tw-bs ol li a font-measurement:13px; .most-widget.squares margin-backside: 40px; .most-widget.squares .most-wrapper:nth-child(strange) margin-left: 0px; margin-correct: 2%; .most-widget.squares .most-wrapper:nth-child(even) margin-correct: 0px; margin-left: 2%; .most-widget.squares .most-wrapper padding: 5px; border: 1px strong #e1e1e1; width: 48%; float: left; margin: 1%; height: 300px; .most-widget.squares .tw-bs ol list-fashion-place: backyard; padding-left: 18px; font-size: 16px; font-family unit:Georgia, instances, serif; .most-widget.squares .tw-bs ol li margin-backside: 13px; .most-widget.squares .tw-bs ol li a font-size: 15px; font-family unit:Georgia, instances, serif; .most-widget.squares .advert-wrapper width: 300px; margin: auto; padding-excellent: 15px; ]]> Commenting policy | how to record abuse Commenting coverage | a way to report abuse